Cooper Share Holder Equity 2010-2025 | COO

Cooper share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Cooper share holder equity for the quarter ending January 31, 2025 was $8.128B, a 5.62% increase year-over-year.
  • Cooper share holder equity for 2024 was $8.084B, a 7.05% increase from 2023.
  • Cooper share holder equity for 2023 was $7.551B, a 5.24% increase from 2022.
  • Cooper share holder equity for 2022 was $7.175B, a 3.35% increase from 2021.
Cooper Annual Share Holder Equity
(Millions of US $)
2024 $8,084
2023 $7,551
2022 $7,175
2021 $6,942
2020 $3,825
2019 $3,629
2018 $3,308
2017 $3,176
2016 $2,696
2015 $2,674
2014 $2,588
2013 $2,423
2012 $2,213
2011 $1,937
2010 $1,667
2009 $1,540
Cooper Quarterly Share Holder Equity
(Millions of US $)
2025-01-31 $8,128
2024-10-31 $8,084
2024-07-31 $7,925
2024-04-30 $7,804
2024-01-31 $7,695
2023-10-31 $7,551
2023-07-31 $7,529
2023-04-30 $7,378
2023-01-31 $7,336
2022-10-31 $7,175
2022-07-31 $7,083
2022-04-30 $7,014
2022-01-31 $6,926
2021-10-31 $6,942
2021-07-31 $6,785
2021-04-30 $6,163
2021-01-31 $5,990
2020-10-31 $3,825
2020-07-31 $3,760
2020-04-30 $3,628
2020-01-31 $3,731
2019-10-31 $3,629
2019-07-31 $3,616
2019-04-30 $3,542
2019-01-31 $3,426
2018-10-31 $3,308
2018-07-31 $3,227
2018-04-30 $3,188
2018-01-31 $3,156
2017-10-31 $3,176
2017-07-31 $3,093
2017-04-30 $2,940
2017-01-31 $2,819
2016-10-31 $2,696
2016-07-31 $2,737
2016-04-30 $2,745
2016-01-31 $2,607
2015-10-31 $2,674
2015-07-31 $2,694
2015-04-30 $2,616
2015-01-31 $2,517
2014-10-31 $2,588
2014-07-31 $2,676
2014-04-30 $2,562
2014-01-31 $2,454
2013-10-31 $2,423
2013-07-31 $2,438
2013-04-30 $2,336
2013-01-31 $2,250
2012-10-31 $2,213
2012-07-31 $2,097
2012-04-30 $2,038
2012-01-31 $1,937
2011-10-31 $1,937
2011-07-31 $1,888
2011-04-30 $1,810
2011-01-31 $1,722
2010-10-31 $1,667
2010-07-31 $1,594
2010-04-30 $1,543
2010-01-31 $1,552
2009-10-31 $1,540
2009-07-31 $1,514
2009-04-30 $1,429
2009-01-31 $1,379
Sector Industry Market Cap Revenue
Medical MED/DENTAL-SUPP $16.458B $3.895B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) US $88.782B 24.29
Becton Dickinson (BDX) US $48.463B 11.98
Cardinal Health (CAH) US $36.122B 18.69
Labcorp (LH) US $20.729B 16.81
Straumann Holding AG (SAUHY) CH $20.028B 0.00
West Pharmaceutical Services (WST) US $15.180B 31.82
Align Technology (ALGN) US $13.165B 25.87
Henry Schein (HSIC) US $8.000B 13.78
Merit Medical Systems (MMSI) US $5.654B 27.33
DENTSPLY SIRONA (XRAY) US $2.806B 8.43
CONMED (CNMD) US $1.784B 13.35
STAAR Surgical (STAA) US $0.942B 0.00
Pro-Dex (PDEX) US $0.150B 16.38
Lifevantage (LFVN) US $0.149B 16.54